Ana sayfa
Piyasalar
Grafikler ve fikirler
Algo
Haberler
Store
Aracı kurumlar
İndir
Ekonomik Takvim
Alım-satım sinyalleri
Web Terminali
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
LUNG
#3421
Pulmonx Corporation Common Stock
1.5
8
+0.64%
Sektör:
Baz:
Kar para birimi:
Günlük aralık
Yıllık aralık
Günlük değişim
+0.64%
Aylık değişim
-9.71%
6 aylık değişim
-15.05%
Yıllık değişim
-81.28%
Önceki kapanış
1.5
7
Open
1.5
8
Bid
Ask
Low
1.5
8
High
1.5
8
Hacim
26
Piyasalar
ABD hisse senetleri
Sağlık hizmetleri
LUNG
Open full chart
Financials
Overview
Rapor
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
35.69 M
37.02 M
37.65 M
38.54 M
39.8 M
—
Valuation ratios
Enterprise value
2.23 B
1.04 B
180.25 M
443.12 M
236.49 M
564.65 M
Price to earnings ratio
21.81
-23.76
-4.71
-7.94
-4.72
-12.35
Price to sales ratio
21.48
23.93
5.18
7.02
3.17
8.04
Price to cash flow ratio
22.97
27.99
6.16
12.83
8.43
21.84
Price to book ratio
3.11
6
1.8
4.08
3.09
4.37
Enterprise value to EBITDA ratio
-73.13
-22.78
-3.23
-7.4
-4.18
-10.01
Profitability ratios
Return on assets %
0.12
0.21
0.3
0.34
0.35
0.38
Return on equity %
0.14
0.25
0.38
0.51
0.66
0.79
Return on invested capital %
583.31
604.01
600.18
430.49
308.81
385.97
Gross margin %
64.77
73.59
74.29
73.9
74
293.29
Operating margin %
98.77
97.7
109.27
90.19
68.87
250.06
EBITDA margin %
-93.23
-94.16
-103.93
-87.17
-67.52
-242.82
Net margin %
98.47
100.51
109.8
88.6
67.3
248.05
Liquidity ratios
Quick ratio
19.1
10.92
8.35
5.77
4.88
17.96
Current ratio
19.96
11.85
9.14
6.5
5.58
20.75
Inventory turnover
1.07
0.95
0.89
1.14
1.29
1.47
Asset turnover
0.12
0.19
0.25
0.37
0.49
0.6
Solvency ratios
Debt to assets ratio
—
—
—
0.21
0.23
1
Debt to equity ratio
—
—
—
0.31
0.43
2.07
Long term debt to total assets ratio
0
0
0
0.2
0.21
0.92
Long term debt to total equity ratio
0
0
0
0.3
0.4
1.93
Per share metrics
Operating cash flow per share
3
1.15
1.22
0.99
0.81
0.8
EBIT per share
-3.17
-1.31
-1.58
-1.63
-1.48
-1.43
EBITDA per share
-3
-1.26
-1.5
-1.58
-1.45
-1.38
Total debt per share
—
—
—
0.98
0.95
3.71
Cash per share
22.74
4.98
3.8
2.2
1.81
7.42
Net current asset value per share
24.55
5.76
4.55
3.96
3.48
12.27
Tangible book value per share
21.94
5.28
4.09
3.05
2.13
7.08
Working capital per share
23.32
5.27
4.06
3.35
2.86
9.91
Book value per share
22.2
5.35
4.15
3.12
2.19
7.31
Haberler
Fulgent Genetics, Inc. (FLGT) Q4 Earnings Top Estimates
Privia Health (PRVA) Q4 Earnings and Revenues Beat Estimates
Pulmonx CEO French, LUNG hisselerinde 13,8 bin dolarlık satış gerçekleştirdi
Stifel, 3Ç sonuçları sonrası Pulmonx hisse senedi notunu Al’da tuttu
Pulmonx stock rating reiterated at Buy by Stifel after 3Q results
Pulmonx kazancı $0,08 ile beklentilere göre daha iyi, kâr ise beklentilere göre yüksek
Pulmonx earnings beat by $0.08, revenue topped estimates
Pulmonx Corporation (LUNG) Reports Q3 Loss, Beats Revenue Estimates
Cisco, Flutter, Manulife and more set to report earnings Wednesday
American Well Corporation (AMWL) Reports Q3 Loss, Beats Revenue Estimates
Canaccord Genuity, liderlik değişiklikleri arasında Pulmonx hissesi için Al tavsiyesini yineliyor
Canaccord Genuity reiterates Buy rating on Pulmonx stock amid leadership changes